Phenazine-1-carboxylic Acid: Function and Applications

Phenazine-1-carboxylic acid, usually abbreviated PCA, is a nitrogen-containing compound produced naturally by several species of soil bacteria, and it functions as both a chemical weapon against competing microbes and a metabolic tool for the bacteria that make it. PCA is the foundational molecule in a family of redox-active phenazines, serving as the precursor from which more complex derivatives are built. Its practical value has attracted attention across agriculture, fermentation science, and even early-stage cancer research, though its most established role remains the suppression of plant-pathogenic fungi in the soil around crop roots.

How Bacteria Build PCA

PCA production traces back to a cluster of seven genes, designated phzA through phzG, that together encode the enzymatic machinery needed to convert a common metabolic intermediate into PCA. In Pseudomonas fluorescens 2-79, one of the best-studied producer strains, these seven genes sit on a stretch of DNA roughly 6,800 base pairs long. Four of the gene products (PhzC, PhzD, PhzE, and PhzF) are essential for PCA synthesis, with the first three resembling enzymes involved in the shikimate pathway, the same biochemical route plants and microbes use to make aromatic amino acids.¹ The bacterium essentially diverts building blocks from this central metabolic highway into phenazine production.

Some species carry redundant copies of the entire operon. Pseudomonas aeruginosa, for instance, has two nearly identical sets of phenazine biosynthetic genes (phz1 and phz2) that encode overlapping but not fully interchangeable functions. Both catalyze PCA synthesis, but they are regulated differently depending on the environment, and they play distinct roles in the organism’s ability to cause disease.² This redundancy appears to give the bacterium flexibility, allowing it to fine-tune PCA output under different conditions rather than relying on a single on-off switch.

Upstream of the biosynthetic genes, a regulatory cascade determines when PCA production gets activated. In Pseudomonas chlororaphis 30-84, the GacS/GacA two-component system serves as a master switch, controlling hundreds of genes, including the phenazine biosynthetic genes and several regulatory genes that feed into phenazine production. When GacA is knocked out, phenazine gene expression drops sharply.³ The system integrates signals about population density and environmental stress, so bacteria typically ramp up PCA production when they have enough neighbors to make the investment worthwhile and when conditions favor competition for resources.

What PCA Does for the Bacteria That Make It

It would be easy to think of PCA as purely a weapon, a toxin aimed at competitors. That is part of the story, but the molecule plays several other roles in the daily life of its producers. Phenazines in general, including PCA, serve as electron shuttles that can ferry electrons to alternative terminal acceptors when oxygen is scarce. They modify the redox balance inside cells, act as signaling molecules that influence gene expression, contribute to the physical architecture of biofilms, and improve long-term survival.⁴

The electron-shuttling function is particularly interesting. Under low-oxygen conditions, PCA can be oxidized biologically and coupled to anaerobic respiration using terminal electron acceptors like nitrate, fumarate, or dimethyl sulfoxide.⁵ In other words, PCA helps bacteria breathe when oxygen is limited. This is valuable in soil environments where oxygen diffusion can be patchy and unreliable, especially deep within biofilms or waterlogged root zones.

PCA also gives its producers access to iron, one of the most competed-over nutrients in soil. In Pseudomonas aeruginosa, a mutant strain unable to produce the usual iron-grabbing molecules (siderophores) can still form biofilms when PCA is present. PCA appears to reduce ferric iron to the more soluble ferrous form, making it biologically available. When iron was locked up by an iron-binding protein, biofilm formation stalled, but adding PCA rescued it.⁶ So PCA is not just an antibiotic; it is also an iron-acquisition strategy.

This iron chemistry extends beyond the immediate needs of the bacterium. PCA-producing bacteria can reductively dissolve poorly crystalline iron and manganese oxides in soil. A related phenazine, phenazine-1-carboxamide, has been shown to act as a recycled electron shuttle rather than a one-time iron chelator, meaning a small amount of phenazine can mobilize a large amount of mineral iron through repeated redox cycling.⁷ In the rhizosphere of wheat grown in dryland conditions, PCA-producing bacteria enhanced the reactivity of iron minerals compared to non-producers.⁸

Biofilm Formation and Rhizosphere Survival

PCA’s contribution to biofilm development has real consequences for how its producers persist in soil. In dryland wheat fields, biofilms formed by a PCA-producing Pseudomonas strain were more robust than those formed by an otherwise identical strain lacking PCA production. The PCA-producing bacteria also showed slower turnover of their biomass in the rhizosphere, suggesting they were better anchored and longer-lived on root surfaces. Interestingly, this advantage was specific to dry conditions; in irrigated soils, the pattern reversed and the PCA-deficient strain formed comparable or better biofilms.⁹ This hints that PCA’s biofilm-promoting role may be most critical under stressful, water-limited conditions where the electron-shuttling and mineral-reduction functions have the highest payoff.

Beyond biofilm integrity, phenazine production helps bacteria compete against the diverse microbial community already present in natural soil. In experiments tracking bacterial populations over multiple planting cycles of wheat, strains unable to make phenazines declined faster than their phenazine-producing counterparts. Phenazine biosynthesis was particularly critical during later planting cycles and in the presence of the take-all fungal pathogen, conditions where competitive pressure from other microbes was highest. In sterilized soil, the non-producing mutants colonized roots just as well as wild-type strains, confirming that the advantage of phenazine production comes specifically from outcompeting other microorganisms.¹⁰

How PCA Kills Fungi

PCA’s antifungal action appears to center on oxidative damage. When the wood-rotting fungus Phellinus noxius was exposed to PCA, intracellular levels of reactive oxygen species climbed sharply. At a dose of 20 micrograms per milliliter, fluorescence measurements of ROS production jumped roughly threefold compared to untreated controls. PCA also triggered hyperpolarization of the mitochondrial membrane, suppressed superoxide dismutase activity (one of the fungus’s own antioxidant defenses), and altered the expression of genes involved in detoxification and electron transport.¹¹ The picture that emerges is one of PCA overwhelming the fungal cell’s ability to manage oxidative stress, while simultaneously disrupting the mitochondria that generate its energy.

Similar mechanisms have been documented in other fungal targets. In Pestalotiopsis kenyana, PCA damaged the mitochondrial membrane potential and compromised the integrity of the cell membrane itself.¹² The consistency of this oxidative-damage mechanism across unrelated fungal species suggests it is not a narrow, easily-evaded trick but rather a fundamental vulnerability that PCA exploits: fungal mitochondria cannot cope with the flood of reactive oxygen species that PCA’s redox cycling generates.

Agricultural Biocontrol of Wheat Diseases

The most thoroughly documented real-world application of PCA is suppressing take-all, a root disease of wheat caused by the fungus Gaeumannomyces graminis var. tritici. This disease has historically been difficult to control with synthetic fungicides because the pathogen attacks the roots directly, where chemical sprays rarely reach. PCA-producing strains of Pseudomonas fluorescens offered a different approach: coat the seed with the bacteria, let them colonize the root system, and rely on PCA production at the site of infection.

The evidence for this dates back decades. When mutant strains of P. fluorescens 2-79 that had lost the ability to produce PCA were tested alongside the wild-type, the mutants provided significantly less take-all suppression on wheat seedlings and were unable to inhibit the pathogen in lab assays.¹³ In both sterilized and natural soils, roots where PCA was detectable had less disease than roots where it was not, establishing a direct link between the presence of the antibiotic in the rhizosphere and disease suppression.¹⁴

The range of fungal targets goes beyond take-all. PCA-producing Pseudomonas strains have shown antagonistic activity against Botrytis cinerea, Colletotrichum gloeosporioides, Fusarium oxysporum, and Rhizoctonia solani in laboratory assays.¹⁵ This broad spectrum makes sense given the oxidative-damage mechanism described above: any fungus vulnerable to ROS flooding is a potential target, regardless of its taxonomy.

PCA has reached the market in at least one country. It is registered in China as a fungicide for use against rice sheath blight, making it one of the few phenazine-based products with formal regulatory approval for crop protection.¹⁶ In the United Kingdom, however, PCA has not been approved for use as a plant protection agent, reflecting the different regulatory timelines and evidentiary standards across jurisdictions.

What Happens When Engineered Strains Enter the Field

An obvious question follows from the biocontrol work: if you genetically engineer a bacterium to produce PCA, does it disrupt the existing soil microbiome? Field trials with a modified Pseudomonas putida strain carrying the phz biosynthetic genes found that PCA was detectable in the rhizosphere of treated wheat plants and that the phz genes remained stable in the introduced bacteria. All introduced strains, whether PCA-producing or not, declined from initial densities of about ten million colony-forming units per gram of rhizosphere sample to below detection limits by harvest time.¹⁷ The introduced bacteria did not persist permanently, and PCA production in the field was temporary. This is reassuring from an environmental standpoint, though it also underscores a practical challenge: if the biocontrol agent cannot sustain itself in the soil, reapplication every growing season may be necessary.

Scaling Up PCA Production

Getting useful quantities of PCA out of a fermentation vessel requires careful optimization. Early work with Pseudomonas sp. M18G identified glucose as the best carbon source and soy peptone as the preferred nitrogen source, with sodium chloride concentration also playing a significant role. Using statistical optimization methods, researchers pushed PCA yields from roughly 670 micrograms per milliliter to nearly 970 micrograms per milliliter by fine-tuning those three variables.¹⁸

A more dramatic improvement came from combining two regulatory mutations in the same strain. A double mutant of Pseudomonas sp. M18, modified in both the gacA and qscR genes, produced over 4,000 milligrams per liter of PCA under optimized conditions, roughly two to three times what either single mutant could manage and far above what the wild-type strain yields.¹⁹ This production level was described as economically viable for industrial use, crossing a threshold that makes commercial-scale manufacturing feasible.

Researchers have also explored heterologous production, engineering phenazine biosynthetic gene clusters into non-native hosts. One team cloned and refactored a cryptic phenazine-type gene cluster from a marine actinomycete, Streptomyces sp. CNB-091, achieving increased production and chemical diversity of phenazine compounds in the engineered host. This strategy opens the door to producing not just PCA but structurally novel phenazine derivatives that the original producer might make only in trace amounts or not at all under laboratory conditions.

Chemical Derivatives and Modifications

PCA is valuable as a molecule in its own right, but it also serves as a chemical scaffold. Because the phenazine ring system is relatively easy to modify at the carboxylic acid group, chemists have synthesized a range of PCA derivatives including the methyl ester, the carboxamide, the hydroxymethyl form, and the acetoxymethyl variant. These were tested against eleven plant-pathogenic fungal species to see whether structural tweaks could improve antifungal potency or broaden the spectrum of activity.²⁰ Similarly, piperazine-containing derivatives of PCA have been synthesized and evaluated for biological activity, with the goal of developing more potent or more stable crop protection agents.¹⁶

This medicinal-chemistry approach treats PCA the way drug developers treat lead compounds: start with a molecule that has proven biological activity, then systematically alter its structure to improve its pharmacological or agrochemical properties. The carboxylic acid group at position 1 is the main handle for modification, but the phenazine ring itself has additional positions where substituents can be added. This structural flexibility is one reason phenazines have attracted interest beyond agriculture.

Biodegradation and Environmental Fate

Any compound used in agriculture raises the question of what happens to it after it has done its job. PCA does not simply accumulate. Certain soil bacteria can break it down and even use it as a sole carbon source for growth. Mycobacterium fortuitum, for example, carries a set of conserved genes that enable it to degrade PCA and two other Pseudomonas-derived phenazines. When those genes were deleted, the degradation phenotype disappeared. This degradation is not just disposal: it generates energy for the mycobacteria and protects organisms that would otherwise be harmed by phenazine toxicity.²¹

The specific biochemistry of PCA breakdown has been studied in Sphingomonas sp. DP58, a strain isolated from soil that can transform PCA into at least two identifiable metabolites. These metabolites appear to be interconvertible intermediates in a degradation pathway that ultimately dismantles the phenazine ring.²² The existence of multiple unrelated bacterial species capable of breaking down PCA suggests that phenazine degradation is widespread in soil microbial communities, meaning environmental persistence is unlikely to be a major concern in agricultural settings.

Early-Stage Anticancer Research

The same oxidative-damage mechanism that makes PCA effective against fungi has drawn attention from cancer researchers. In laboratory experiments, PCA inhibited the proliferation of a human prostate cancer cell line in a dose- and time-dependent manner. The molecule triggered a cascade of events: elevated reactive oxygen species activated a pro-apoptotic signaling pathway, which depolarized mitochondrial membranes, shifted the balance between anti-apoptotic and pro-apoptotic proteins, and ultimately led to programmed cell death through both caspase-dependent and caspase-independent routes.²³

This is very early work, conducted entirely in cell culture. The gap between killing cancer cells in a dish and developing a viable therapeutic is enormous, and PCA’s redox activity could easily prove too nonspecific to be safe in a patient. Still, the finding that the same oxidative stress mechanism operates across such different target cells (fungi, human cancer lines) reinforces the generality of PCA’s mode of action and keeps it on the radar as a scaffold for drug discovery. No clinical trials in humans are currently underway, and any medical application would be years of development away at minimum.

Phenazine Diversity Beyond PCA

PCA sits at the base of a larger family. In nature, the seven core biosynthetic genes produce PCA, which bacteria then modify using additional, species-specific enzymes to generate structurally distinct phenazines. Pseudomonas aeruginosa, for example, converts PCA into pyocyanin, the blue-green pigment responsible for the characteristic color of infected wounds. Pseudomonas chlororaphis produces phenazine-1-carboxamide from PCA. Other species tack on hydroxyl groups, methyl groups, or more elaborate decorations. The structural diversity of natural phenazines is substantial, with representatives found across Pseudomonas, Streptomyces, Burkholderia, and other genera. Horizontal gene transfer has spread phenazine biosynthetic genes between distantly related species over evolutionary time, which helps explain why this metabolic capability pops up in bacterial lineages that otherwise have little in common. Each derivative has a somewhat different balance of redox potential, solubility, and toxicity, giving the producing bacterium a tailored chemical toolkit shaped by the specific ecological niche it occupies.